Stockholders' Equity Attributable to Parent in USD of Elevation Oncology, Inc. from Q4 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Elevation Oncology, Inc. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q4 2019 to Q1 2025.
  • Elevation Oncology, Inc. Stockholders' Equity Attributable to Parent for the quarter ending March 31, 2025 was $46.7M, a 38.4% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Elevation Oncology, Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $46.7M -$29.1M -38.4% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $60M +$5.22M +9.52% Dec 31, 2024 10-Q 2025-05-15
Q3 2024 $69.4M +$6.94M +11.1% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $80.9M +$8.74M +12.1% Jun 30, 2024 10-Q 2024-11-06
Q1 2024 $75.8M +$42.1M +125% Mar 31, 2024 10-Q 2025-05-15
Q4 2023 $54.8M +$5.78M +11.8% Dec 31, 2023 10-Q 2025-05-15
Q3 2023 $62.4M -$4.71M -7.01% Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $72.2M -$32.5M -31% Jun 30, 2023 10-Q 2024-11-06
Q1 2023 $33.8M -$90.1M -72.7% Mar 31, 2023 10-Q 2024-08-06
Q4 2022 $49M -$91.7M -65.2% Dec 31, 2022 10-K 2025-03-06
Q3 2022 $67.1M -$82.5M -55.1% Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $105M -$50.7M -32.6% Jun 30, 2022 10-Q 2023-11-02
Q1 2022 $124M +$152M Mar 31, 2022 10-Q 2023-08-03
Q4 2021 $141M +$164M Dec 31, 2021 10-K 2024-03-06
Q3 2021 $150M +$164M Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $155M +$167M Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$28.1M -$20.3M -259% Mar 31, 2021 10-Q 2022-08-04
Q4 2020 -$23.1M -$17.2M -293% Dec 31, 2020 10-K 2023-03-09
Q3 2020 -$14.2M Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$11.2M Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$7.82M Mar 31, 2020 10-Q 2021-08-12
Q4 2019 -$5.87M Dec 31, 2019 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.